ESC 365 - AF in HFrEF, HFmrEF and HFpEF: does it make any difference?

EHRA Premium Access

AF in HFrEF, HFmrEF and HFpEF: does it make any difference?

Session: Atrial fibrillation (AF) in HFrEF, HFmrEF and HFpEF: does it make any difference?

Topic: Heart Failure in Atrial Fibrillation

Speaker: Professor R. De Boer (Groningen, NL)

Event: EHRA 2022

Presentation

About the speaker

Professor Rudolf De Boer

University Medical Center Groningen, Groningen (Netherlands (The))

41 presentations

0 follower

4 more presentations in this session

SGLT2 blockers in AF: the best AAD ever?

Speaker: Professor F. Ruschitzka (Zurich, CH)

Insights from the Castle AF: why was it positive?

Speaker: Professor N. Marrouche (New Orleans, US)

The future of AF ablation in heart failure.

Speaker: Professor D. Gupta (Liverpool, GB)

Atrial Fibrillation (AF) in HFrEF, HFmrEF and HFpEF: does it make any difference? - discussion.

Access the full session

Atrial fibrillation (AF) in HFrEF, HFmrEF and HFpEF: does it make any difference?

Speakers: Professor R. De Boer, Professor F. Ruschitzka, Professor N. Marrouche, Professor D. Gupta

About the event

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Congress

Related content

Open Access

Hot topics in atrial fibrillation.

5 April 2022

EHRA Premium Access

EHRA expect consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex.

3 April 2022

EHRA Premium Access

EHRA position paper on leadless pacing and extravascular defibrillators.

3 April 2022

This platform is supported by